Upstream Bio (UPB) PT Lowered to $43 at Truist Securities
Tweet Send to a Friend
Truist Securities analyst Danielle Brill lowered the price target on Upstream Bio (NASDAQ: UPB) to $43.00 (from $47.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
